Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
An ongoing Phase 3 study evaluating long-term treatment with bimekizumab in adults with moderate to severe hidradenitis suppurativa; the stu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of SAR445399 in adults with moderate to severe hidra…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa [Phase 2]
A Phase 2 proof-of-concept clinical trial of LAD328 in adults with hidradenitis suppurativa has been announced, with recruitment not yet sta…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
This is a long-term observational study in Italy to collect real-world data on how Secukinumab is used to treat hidradenitis suppurativa in …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
This document describes an ongoing long-term observational study collecting real-world data on how secukinumab is used to treat adults with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
This clinical trial update describes a long-term observational study to evaluate the safety of a gene-modified regulatory T cell therapy in …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of topical ruxolitinib cream in hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
A real-world data study sponsored by Novartis to collect how secukinumab is used in adults with moderate to severe hidradenitis suppurativa …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Real-world Secukinumab Outcomes in Canadian HS Patients
A real-world study evaluating secukinumab for hidradenitis suppurativa in Canadian patients is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Brivekimig is being studied in a Phase 2 trial for moderate to severe hidradenitis suppurativa, with recruitment currently ongoing.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of topical ruxolitinib cream for hidradenitis suppurativa, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa [Phase 2, Phase 3]
A Phase 2/3 trial of BFB759 for moderate to severe hidradenitis suppurativa is currently recruiting, sponsored by Bluefin Biomedicine, Inc.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) [Phase 1]
A Phase 1 study is evaluating the concentration of Bimzelx (bimekizumab) in mature breast milk in mothers receiving treatment, and is curren…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.
Clinical trial update assessing short-term treatment satisfaction and quality of life in hidradenitis suppurativa patients initiated on secu…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Clinical trial update notes ongoing sample collection from participants with acne, atopic dermatitis, chronic hand eczema, hidradenitis supp…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
This is a Phase 3 study to assess pharmacokinetics and safety of Bimekizumab in children and adolescents with moderate to severe hidradeniti…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study With CIT-013 in HS Patients [Phase 2]
This clinical trial update reports that a Phase 2 study of CIT-013 in hidradenitis suppurativa is currently recruiting. The sponsor is Citry…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 clinical trial to evaluate disease activity and safety of Lutikizumab in adults and adolescents with moderate to severe hidradenit…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Clinical and Biological Characteristics of Hidradenitis Suppurativa
A UCSF-led clinical study investigating the clinical and biological characteristics of hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
This ClinicalTrials.gov entry describes a prospective observational registry and biospecimen repository for hidradenitis suppurativa and is …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) [Phase 3]
A Phase 3 study (RECHARGE 1) to assess the efficacy, safety, and tolerability of remibrutinib in adults and adolescents with moderate to sev…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate the efficacy, safety, and tolerability of remibrutinib in adults and adolescents with mod…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
A real-world study evaluating outcomes in patients with hidradenitis suppurativa and high cardiovascular risk or established coronary plaque…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Zasocitinib in Adults With Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating Zasocitinib in adults with hidradenitis suppurativa is currently recruiting.